turoctocog alfa
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Factor VIII (FVIII) is indicated for the prevention or treatment of bleeding in patients with hemophilia A. FVIII product…
Summary Turoctocog alfa (NovoEight®) is a new recombinant factor VIII (rFVIII) with a truncated B domain and a high degree of…
Hemophilia A (HA) represents one of the most common genetic bleeding disorders worldwide and results from a deficiency in factor…